Search Results - "GLASSMAN, R. M"

Postnatal development of corneal endothelium by BAHN, C. F, GLASSMAN, R. M, MACCALLUM, D. K, LILLIE, J. H, MEYER, R. F, ROBINSON, B. J, RICH, N. M

“…Comparison specular micrographs of infant and adult corneas from cats, cows, dogs, rabbits, and humans demonstrate that a large decrease in central endothelial…”
Get full text

Endogenous Klebsiella endophthalmitis: case report by Glassman, R M, Lieberman, T T, Friedman, A H, Fuchs, W, Meltzer, M A, Gabrilove, L

“…A case of endogenous Klebsiella pneumoniae endophthalmitis, cryptogenic in origin, is presented. It was treated initially with success, only to recur three…”
Get more information

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results by Elman, Michael J., MD, Ayala, Allison, MS, Bressler, Neil M., MD, Browning, David, MD, Flaxel, Christina J., MD, Glassman, Adam R., MS, Jampol, Lee M., MD, Stone, Thomas W., MD

“…Objective To report 5-year results from a previously reported trial evaluating intravitreal 0.5 mg ranibizumab with prompt versus deferred (for ≥24 weeks)…”
Get full text

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema by Elman, Michael J., MD, Bressler, Neil M., MD, Qin, Haijing, MS, Beck, Roy W., MD, PhD, Ferris, Frederick L., MD, Friedman, Scott M., MD, Glassman, Adam R., MS, Scott, Ingrid U., MD, MPH, Stockdale, Cynthia R., MSPH, Sun, Jennifer K., MD, MPH

“…Objective To report expanded 2-year follow-up of a previously reported randomized trial evaluating intravitreal 0.5 mg ranibizumab or 4 mg triamcinolone…”
Get full text

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema by Elman, Michael J., MD, Aiello, Lloyd Paul, MD, PhD, Beck, Roy W., MD, PhD, Bressler, Neil M., MD, Bressler, Susan B., MD, Edwards, Allison R., MS, Ferris, Frederick L., MD, Friedman, Scott M., MD, Glassman, Adam R., MS, Miller, Kellee M., MPH, Scott, Ingrid U., MD, MPH, Stockdale, Cynthia R., MSPH, Sun, Jennifer K., MD, MPH

“…Objective Evaluate intravitreal 0.5 mg ranibizumab or 4 mg triamcinolone combined with focal/grid laser compared with focal/grid laser alone for treatment of…”
Get full text

Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy by Lim, Jennifer I., MD, Glassman, Adam R., MS, Aiello, Lloyd Paul, MD, PhD, Chakravarthy, Usha, MD, Flaxel, Christina J., MD, Spaide, Richard F., MD

“…Purpose To assess the visual and anatomic outcomes of central serous chorioretinopathy (CSC) after verteporfin photodynamic therapy (PDT). Design Retrospective…”
Get full text

Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab by Bressler, Susan B., MD, Beaulieu, Wesley T., PhD, Glassman, Adam R., MS, Gross, Jeffrey G., MD, Jampol, Lee M., MD, Melia, Michele, ScM, Peters, Mark A., MD, Rauser, Michael E., MD

“…Purpose To compare rates and identify predictive factors for events that represent worsening of proliferative diabetic retinopathy (PDR) in eyes treated with…”
Get full text

Ten dietary topics for the dental practitioner - a review by Touyz, L Z, Glassman, R M

Get more information

Citrus, acid and teeth by Touyz, L Z, Glassman, R M

Get more information

Ten dietary topics for the dental practitioner--a review by Touyz, L Z, Glassman, R M

Get more information

Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-Involved Diabetic Macular Edema by Aiello, Lloyd Paul, MD, PhD, Beck, Roy W., MD, PhD, Bressler, Neil M., MD, Browning, David J., MD, PhD, Chalam, K.V., MD, Davis, Matthew, MD, Ferris, Frederick L., MD, Glassman, Adam R., MS, Maturi, Raj K., MD, Stockdale, Cynthia R., MSPH, Topping, Trexler M., MD

“…Objective To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti–vascular endothelial growth factor…”
Get full text

Factors Associated with Improvement and Worsening of Visual Acuity 2 Years after Focal/Grid Photocoagulation for Diabetic Macular Edema by Aiello, Lloyd Paul, MD, PhD, Edwards, Allison R., MS, Beck, Roy W., MD, PhD, Bressler, Neil M., MD, Davis, Matthew D., MD, Ferris, Frederick, MD, Glassman, Adam R., MS, Ip, Michael S., MD, Miller, Kellee M., MPH

“…Purpose To identify factors associated with the visual acuity outcome after focal/grid photocoagulation for diabetic macular edema (DME) among eyes randomized…”
Get full text

Reply by Wells, John A., MD, Glassman, Adam R., MS, Ayala, Allison R., MS, Jampol, Lee M., MD

Get full text

Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases by Beck, Roy W., MD, PhD, Maguire, Maureen G., PhD, Bressler, Neil M., MD, Glassman, Adam R., MS, Lindblad, Anne S., PhD, Ferris, Frederick L., MD

“…Purpose Visual acuity (VA) is the primary outcome measure in many studies involving eye diseases. A standard statistical approach for comparing a continuous…”
Get full text

Optical Coherence Tomography Measurements and Analysis Methods in Optical Coherence Tomography Studies of Diabetic Macular Edema by Browning, David J., MD, PhD, Glassman, Adam R., MS, Aiello, Lloyd P., MD, PhD, Bressler, Neil M., MD, Bressler, Susan B., MD, Danis, Ronald P., MD, Davis, Matthew D., MD, Ferris, Frederick L., MD, Huang, Suber S., MD, Kaiser, Peter K., MD, Kollman, Craig, PhD, Sadda, Srinavas, MD, Scott, Ingrid U., MD, MPH, Qin, Haijing, MS

“…Objective To evaluate optical coherence tomography (OCT) measurements and methods of analysis of OCT data in studies of diabetic macular edema (DME). Design…”
Get full text

Reply by Wells, John A., MD, Glassman, Adam R., MS, Jampol, Lee M., MD, Ayala, Allison, MS, Bressler, Neil M., MD

Get full text

Reply by Wells, John A., MD, Glassman, Adam R., MS, Bressler, Neil M., MD, Ayala, Allison R., MS, Jampol, Lee M., MD

Get full text

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema by Wells, John A., MD, Glassman, Adam R., MS, Ayala, Allison R., MS, Jampol, Lee M., MD, Bressler, Neil M., MD, Bressler, Susan B., MD, Brucker, Alexander J., MD, Ferris, Frederick L., MD, Hampton, G. Robert, MD, Jhaveri, Chirag, MD, Melia, Michele, ScM, Beck, Roy W., MD, PhD

“…Purpose To provide 2-year results comparing anti–vascular endothelial growth factor (VEGF) agents for center-involved diabetic macular edema (DME) using a…”
Get full text

A Proposed Method of Logarithmic Transformation of Optical Coherence Tomography Data for Use in Clinical Research by Ferris, Frederick L., MD, Miller, Kellee M., MPH, Glassman, Adam R., MS, Beck, Roy W., MD, PhD

“…Purpose To evaluate a logarithmic transformation of retinal thickness measurements from optical coherence tomography as a new approach to assess clinically…”
Get full text

Metastatic Meningioma Extending Into the Left Atrium Through the Pulmonary Vein by Yu, Pey-Jen, MD, Hyman, Kevin M., MD, Cassiere, Hugh A., MD, Fallon, Brian, MD, Vatsia, Sheel K., MD, Esposito, Michael J., MD, Glassman, Lawrence R., MD

“…Left atrial extension of pulmonary tumors through the pulmonary vein is most often associated with primary malignancies and is rarely associated with…”
Get full text